Lung cancer is one of the deadliest types of cancer, and is a public health problem worldwide.
Methotrexate (MTX), a class IV drug in the biopharmaceutical classification system, is a folate antagonist that has demonstrated efficacy in cancer treatment.
A suitable combination of MTX as a di-anion and biocompatible counter ions allowed the modulation of their physicochemical properties.
In this work, twelve MTX salts were prepared and characterized by
